Pharmacy Times » Biosimilars
298 FOLLOWERS
Biosimilars Resource Center is a comprehensive resource for clinical news and expert insights on issues related to biosimilar drugs, a biological product that is highly similar to a reference biologic for which there are no clinically meaningful differences in terms of safety, purity, and efficacy. Pharmacy Times is the leading media resource for pharmacists and the pharmacy industry,..
Pharmacy Times » Biosimilars
17h ago
Tarlatamab is a first-in-class immunotherapy that binds to DLL3 tumor cells and CD3 T-cells, to kill DLL3-expressing SCLC ..read more
Pharmacy Times » Biosimilars
20h ago
Both MetS and obesity status have independent and differential associations with breast cancer, and may serve as separate targets for breast cancer prediction and prevention strategies ..read more
Pharmacy Times » Biosimilars
20h ago
Natalie Bedford, senior vice president, US Pharmaceutical Distribution Services at McKesson, discusses the unique challenges of distributing specialty drugs ..read more
Pharmacy Times » Biosimilars
23h ago
Jodi Taraba offers valuable insights on the benefits of involving oncology pharmacists in clinical trial research to advance treatment and care for patients with cancer ..read more
Pharmacy Times » Biosimilars
23h ago
Future potential directions include measuring the impact of clinical pharmacist interventions on referral utility, disease-specific clinical outcomes, patient satisfaction, medication adherence, and absenteeism ..read more
Pharmacy Times » Biosimilars
23h ago
As summer approaches, remind patients to go back to basics with sunscreen and self-examinations ..read more
Pharmacy Times » Biosimilars
1d ago
Three influencers from around the world showcase the passions they pursue outside the pharmacy industry ..read more
Pharmacy Times » Biosimilars
2d ago
Candy Peskey highlights the necessary role of oncology pharmacists in patient care and enrollment in clinical trials ..read more